Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
09/2005
09/01/2005US20050191300 Immunotherapy of autoimmune disorders using antibodies which target B-cells
09/01/2005US20050191299 Identifying an inhibitor of CD70 by contacting a candidate CD70 inhibitor with a preparation of antigen presenting lamina propria (APCLP) cells; determining response of candidate inhbitor on gene expression of CD70 by said cells, and selecting an inhibitor; high throughput screening
09/01/2005US20050191298 Administering an anti-C5 antibody for treating paroxysmal nocturnal hemoglobinuria blood disorder; reduction in lactate dehydrogenase; biodrug for hemoglobinuria, anemia, hemoglobinemia, dysphagia, fatigue, nitric oxide (NO) deficiency, erectile dysfunction, recurrent abdominal pain and thrombosis
09/01/2005US20050191297 Sampling from biopsy of transplanted graft; administering a CD20 antagonist such as rituximab, humanized 2H7, or antibody conjugated to cytotoxic agent
09/01/2005US20050191296 Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between CD28 and the superantigen and uses thereof
09/01/2005US20050191294 Peptide that selectively binds IL-11 receptor-alpha (IL11R alpha ); prostate and/or bone cancer, or adipose tissue; apoptosis induction; diagnosis, prognosis; staging metastatic cancer
09/01/2005US20050191293 Isolated human monoclonal antibody, or an antigen-binding portion thereof; binds to human IP-10 (nterferon gamma inducible protein); cross-reacts with Rhesus monkey IP-10; inhibits calcium flux and cell migration; does not cross-react with mouse IP-10; autoimmune diseases; antiinflammatory agents
09/01/2005US20050191292 of reversing cognitive decline by administering a humanized antibody that binds to A beta; particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease or Down's syndrome.
09/01/2005US20050191291 Mixing biodegradable devices with T-cells so that one or more agents crosslink with the T-cell surface moieties and deliver a signal to enhance immunostimulatory capabilities;
09/01/2005US20050191289 Complexes of immunoglobulins and polysaccharides for oral and transmucosal absorption
09/01/2005US20050191288 Administering to patient before or simultaneously with surgery at least one heparinase enzyme, wherein heparinase enzyme decreases localized inflammatory response in the tissue of the patient
09/01/2005US20050191285 Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
09/01/2005US20050191283 Methods of treating NFAT-related disorders
09/01/2005US20050191280 Immune regulation
09/01/2005US20050191277 Methods of treating various cancers using melanoma differentiation associated protein-7
09/01/2005US20050191276 Treatment of inflammatory bowel disease through induction of indoleamine 2.3-dioxygenase
09/01/2005US20050191246 Powders comprising low molecular dextran and methods of producing those powders
09/01/2005CA2567042A1 Enrichment methods for the detection of pathogens and other microbes
09/01/2005CA2558770A1 Use of tweak modulators and inhibitors for the treatment of neurological conditions
09/01/2005CA2557837A1 Fructoseamine 3 kinase and the formation of collagen and elastin
09/01/2005CA2557424A1 Methods for protein production
09/01/2005CA2557333A1 Antifungal peptides
09/01/2005CA2556803A1 T cell immune response inhibitor
09/01/2005CA2556425A1 Methods of modulating il-23 activity; related reagents
09/01/2005CA2556141A1 Method and device for detecting feline immunodeficiency virus
09/01/2005CA2556027A1 Monoclonal antibodies that specifically block biological activity of a tumor antigen
09/01/2005CA2555984A1 Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer
09/01/2005CA2555841A1 Interleukin-13 antagonist powders, spray-dried particles, and methods
09/01/2005CA2555694A1 Anti-epcam immunoglobulins
09/01/2005CA2555661A1 Fusion proteins containing recombinant cytotoxic rnases
09/01/2005CA2555641A1 Drug conjugates
09/01/2005CA2555550A1 Galanin receptors and brain injury
09/01/2005CA2555421A1 Agonists and antagonists of p28 ebi3 and wsx/tccr for treating immune disorders
09/01/2005CA2555342A1 Polypeptides for inducing a protective immune response against staphylococcus aureus
09/01/2005CA2555236A1 Methods of modulating cytokine activity; related reagents
09/01/2005CA2555210A1 Chemically programmable immunity
09/01/2005CA2554965A1 Antibodies specific for activated confirmation of lfa-1
09/01/2005CA2554537A1 Method and composition for angiogenesis inhibition
09/01/2005CA2498910A1 Animal immunocontraceptives expressed in plants and uses thereof
08/2005
08/31/2005EP1568777A1 Deletion mutants from Neisseria glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
08/31/2005EP1568767A2 Dna fragments of lav genes
08/31/2005EP1568378A1 Passive immunization against clostridium difficile disease
08/31/2005EP1568376A2 Use of alpha-1 antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds
08/31/2005EP1568373A2 Inducing cellular immune responses to HER2/neu using peptide and nucleic acid compositions
08/31/2005EP1567868A2 Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines
08/31/2005EP1567863A2 Methods of therapy and diagnosis
08/31/2005EP1567663A2 Molecular determinants of myeloma bone disease and uses thereof
08/31/2005EP1567644A2 Tissue specific genes and gene clusters
08/31/2005EP1567641A2 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
08/31/2005EP1567545A2 Peptides, antibodies thereto, and their use in the treatment of central nervous system damage
08/31/2005EP1567544A2 Use of hmgb polypeptides for increasing immune responses
08/31/2005EP1567542A2 Novel inhibin-related multiple antigenic peptide compositions that enhance production performance in avians
08/31/2005EP1567191A1 Novel amine-based adjuvant
08/31/2005EP1567190A2 A hepatitis c virus codon optimized non-structural ns3/4a fusion gene
08/31/2005EP1567189A1 Malaria vaccine
08/31/2005EP1567188A2 Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases
08/31/2005EP1567185A2 Broad spectrum anti-viral therapeutics and prophylaxis
08/31/2005EP1567183A2 Methods and compositions for treatment of otitis media
08/31/2005EP1567178A1 Modulators of receptors for parathyrois hormone and parathyroid hormone-related protein
08/31/2005EP1567175A2 Sterile immunogenic non-tumorigenic tumor cell compositions and methods
08/31/2005EP1567170A2 Use of beta-glucans against biological warfare weapons and pathogens including anthrax
08/31/2005EP1567157A1 Methods of using and compositions comprising immunomudulatory compounds for the treatment and management of myeloproliferative diseases
08/31/2005EP1567155A2 Administration of dendritic cells partially matured in vitro for the treatment of tumors
08/31/2005EP1567123A2 An allergen dosage form
08/31/2005EP1567117A1 Materials and methods for preventing and treating microbe-mediated epithelial disorders
08/31/2005EP1567014A2 Rapid one-step method for generation of antigen loaded dendritic cell vaccine from precursors
08/31/2005EP1095020B1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them
08/31/2005EP1078064B1 Compounds from moraxella catarrhalis
08/31/2005EP1009386B1 Rapid release encapsulated bioactive agents for inducing or potentiating an immune response and methods of using thereof
08/31/2005EP0941333B1 Immunogenic detoxified mutant e. coli lt-a toxin
08/31/2005EP0939653B1 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications
08/31/2005EP0721345B1 Prostatic cancer vaccine
08/31/2005CN1662664A Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
08/31/2005CN1662663A DNA enzyme to inhibit plasminogen activator inhibitor-1
08/31/2005CN1662558A Antibodies specific for human cd22 and their therapeutic anddiagnostic uses
08/31/2005CN1662554A Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
08/31/2005CN1662553A Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions
08/31/2005CN1662548A Regeneration of endogenous myocardial tissue by induction of neovascularization
08/31/2005CN1662254A ALCAM and ALCAM modulators
08/31/2005CN1662253A Packaged virus-like particles for use as adjuvants: method of preparation and use
08/31/2005CN1662251A Adjuvant enhanced immunotherapy
08/31/2005CN1662249A Osteopontin, oligodendrocytes and myelination
08/31/2005CN1661373A New target drone of medication for anti hepatitis b virus and application
08/31/2005CN1660912A Anti IL-8 monoclonal antibody, sequence of its variable region and application
08/31/2005CN1660911A Connective tissue growth factor fragments and methods and uses thereof
08/31/2005CN1660906A Technique for extracting secretion type immunoglobulin sig A in extractive of human colostrum
08/31/2005CN1660900A CUDR as biomarker for cancer progression and therapeutic response
08/31/2005CN1660881A New type molecules of immunization stimulus and preparation method
08/31/2005CN1660439A Thinner for vaccine and preparation method
08/31/2005CN1660427A Extracorporeal photopheresis in combination with anti-tnf treatment
08/31/2005CN1660426A Methods for inhibiting brain tumor growth
08/31/2005CN1660425A Method for preparing biopreparate of vitellus antibody for anti hemorrhagic bacillus coli 0157:117
08/31/2005CN1660424A Method for preparing biologics of yolk antibody for anti Helicobacter Pylori
08/31/2005CN1660423A Monoclonal antibody of distinguished membrane protein for anti lipocyte in use for reducing deposition of subcutaneous fat in pigs
08/31/2005CN1660422A Anticarious preparation of antibody
08/31/2005CN1660421A Bobtail bacterin of neuraminidase for preventing influenza virus and preparing method
08/31/2005CN1216992C Immunomodulators
08/31/2005CN1216985C Hepatitis A virus strain, method for preparing hepatitis A inactivated vaccine and obtained vaccine
08/31/2005CN1216914C Humanized antibody with specificity t HBV surface antigen PRE-S1 and its producing process
08/31/2005CN1216641C Monoclonal human matural antibodies
1 ... 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 ... 1823